Tuberculosis drug shows promise against latent bacteria
Sunday, September 14, 2008 - 08:35
in Health & Medicine
A new study has shown that an investigational drug (R207910, currently in clinical trials against multi-drug resistant tuberculosis strains) is quite effective at killing latent bacteria. This revelation suggests that R207910 may lead to improved and shortened treatments for this globally prevalent disease.